1
5
3
2
8
6
4
7

Large Cap Value Plus

Process

Factor-Based Analysis
Our process begins with factor-based analysis that winnows the universe to the most attractive candidates for fundamental evaluation.
  • Lower valuation – Below-average P/E and above-average yield
  • Higher quality – Below-average P/E and above-average yield
Companies meeting our criteria are ranked based on valuation and quality; this helps focus our fundamental research on the most compelling opportunities.

large cap value plus
Fundamental Research
Fundamental research constitutes the vast majority of the investment team’s efforts, with portfolio managers evaluating every company for consideration in the portfolio. The objective, which is achieved through rigorous analysis and spirited debate, is to evaluate each company’s ability to generate growth in sales, earnings, cash flows, and dividends, as well as the sustainability of its business model and potential risks.

Portfolio Construction
Portfolio construction is a key component of the investment process, with risk controlled at the security, and sector level.
  • Individual positions initiated at 0.5% - 5.0%
  • Typically 40 – 75 positions held
  • Sectors limited to initial net exposure of 4%
large cap value plus

Our weighted average market cap ranges from $2.5 – 3.0 billion, which is in-line with the average small cap manager.

We eliminate MLPs, preferred stocks, and convertibles to ensure investors receive true small cap exposure without esoteric instruments that may cause tax complexities or introduce additional risks.

Sell Discipline
The sell process is also driven by consensus among the portfolio management team, and focuses on valuation, company fundamentals, and portfolio considerations.

We evaluate each holding versus our initial investment thesis in making sell decisions.
  • Valuation
    • Trailing and forecasted P/E ratio well above market
    • Yield well below market
  • Quality Rank
    • Company falls to lowest 20% rank in our quality model
  • Increase in business, financial or management risk.
    • Deterioration in business fundamentals
    • Entrance of new competitors
    • Regulatory / legal concerns
    • Change in capital structure
    • Management turnover
    • Dividend cut
Portfolio considerations may also prompt the sale of a holding
  • Security’s weight in portfolio
  • Industry or sector constraints
  • Region or country constraints
 



     
         
WHAT'S HAPPENING

Walk to Cure Arthritis
  Join us for the 2017 Walk to Cure Arthritis on Sunday, May 21, 2017. If you or your family/friends are interested in participating (or donating), CLICK HERE to join Opus Capital’s team.  There is no cost to participate!                      
  MEET OUR TEAM


  Jakki L. Haussler, Esq., CPA
Founder and CEO

View Bio
Debra Gordon
  Debra Gordon
Director - Marketing
and Client Relations

View Bio

  Nathanael A. Stewart, CFA
Associate Portfolio Manager
and Research Analyst

View Bio
B. Rapking - Operations Associate
  Brad J. Rapking
Equity Trader

View Bio
John A. Ferguson, CFA
  John A. Ferguson, CFA
Principal
and Portfolio Manager

View Bio
Adam T. Eagleston, CFA
  Adam T. Eagleston, CFA
Principal
and Portfolio Manager

View Bio
Joseph P. Condren, CFA
  Joseph P. Condren, CFA
Principal, COO and CCO

View Bio
Nathan A. Bishop, CFA
  Nathan A. Bishop, CFA
Principal
and Portfolio Manager

View Bio
Michael R. Knapke
  Michael R. Knapke
Manager - Marketing and 
Client Relations

View Bio
Matt Mautino
  Matt Mautino
Operations Support

View Bio
Kevin P. Whelan, CFA
  Kevin P. Whelan, CFA
Principal
and Portfolio Manager

View Bio
Len A. Haussler, CFA, CPA
  Len A. Haussler, CFA, CPA
Founder
and Portfolio Manager

View Bio
David W. Wagner III
  David W. Wagner III
Research Analyst


View Bio
Nathan M. Bailey, CFA
  Nathan M. Bailey, CFA
Associate Wealth Advisor

View Bio

  CONTACT INFO

221 E. 4th Street, Suite 2700
Cincinnati, OH 45202
Office: (513) 621-6787
         
Copyright © 2017. Opus Capital Management. All Rights Reserved